<PAGE> 1
----------------------------------
OMB APPROVAL
----------------------------------
OMB Number: 3235-0145
Expires: October 31, 1997
Estimated average burden
hours per response . . . . 14.90
----------------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 3 )*
--------
SUBSTANCE ABUSE TECHNOLOGIES, INC. (FKA U.S. Alcohol Testing of America, Inc.)
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 Par Value Per Share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
91154J101
----------------------------------------------------------
(CUSIP Number)
Scott J. Lederman, Esq. 777 Long Ridge Road, Stamford, Connecticut 06902
(203) 614-2000
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
May 2, 1997
----------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ].
Check the following box if a fee is being paid with the statement [ ]. (A fee
is not required only if the reporting person: (1 has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
NOTE: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are to
be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
SEC 1746 (12-91)
<PAGE> 2
SCHEDULE 13D
- ---------------------------------- ------------------------------------
CUSIP No. 91154J101 Page 2 of 5 Pages
--------------------- ---------- --------
- ---------------------------------- ------------------------------------
<TABLE>
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C>
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
S.A.C. Capital Advisors, LLC
- ----------------------------------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a [x]
(b [ ]
- ----------------------------------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO
- ----------------------------------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
- ----------------------------------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- ----------------------------------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
NONE
SHARES ---------------------------------------------------------------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
3,003,100
OWNED BY ---------------------------------------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
None
REPORTING ---------------------------------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON
3,003,100
WITH
- ----------------------------------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,003,100
- ----------------------------------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [x]
- ----------------------------------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.32% based upon 41,030,591 Shares outstanding (which number represents the 36,030,591 Shares outstanding as
of February 10, 1997 as reported in the Company's Form 10-Q dated February 14, 1997, plus 2,500,000 additional
shares which would be issued by the Company upon conversion of the Notes and the 2,500,000 additional shares
which would be issued by the Company upon exercise of the Warrants)
- ----------------------------------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
00
- ----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
<PAGE> 3
SCHEDULE 13D
- ---------------------------------- ------------------------------------
CUSIP No. 91154J101 Page 3 of 5 Pages
--------------------- ---------- --------
- ---------------------------------- ------------------------------------
<TABLE>
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C>
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steven A. Cohen
- ----------------------------------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a [ ]
(b [ ]
- ----------------------------------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- ----------------------------------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- ----------------------------------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ]
- ----------------------------------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- ----------------------------------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
4,243,100
SHARES -----------------------------------------------------------------------------------------------------------
8 SHARED VOTING POWER
BENEFICIALLY
3,003,100
OWNED BY ----------------------------------------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
EACH
4,243,100
REPORTING ----------------------------------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
PERSON
3,003,100
WITH
- ----------------------------------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
7,246,200
- ----------------------------------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- ----------------------------------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
17.66% based upon 41,030,591 Shares outstanding (which number represents the 36,030,591 Shares outstanding
as of February 10, 1997 as reported in the Company's Form 10-Q dated February 14, 1997, plus 2,500,000
additional shares which would be issued by the Company upon conversion of the Notes and the 2,500,000 additional
shares which would be issued by the Company upon exercise of the Warrants)
- ----------------------------------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- ----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE> 4
SCHEDULE 13D
- ---------------------------------- ------------------------------------
CUSIP No. 91154J101 Page 4 of 5 Pages
--------------------- ---------- --------
- ---------------------------------- ------------------------------------
This Amendment Number 3 to Schedule 13D is filed by Steven A. Cohen ("Cohen")
and S.A.C. Capital Advisors, LLC, a Delaware limited liability company ("SAC
Advisors" and, together with Cohen, the "Reporting Persons"), relating to the
shares of common stock, $0.01 par value per share ("Shares") of Substance Abuse
Technologies, Inc. (formerly known as U.S. Alcohol Testing Centers of America,
Inc.), a Delaware corporation (the "Company"), held by Cohen and S.A.C. Capital
Associates, LLC, an Anguillan limited liability company ("SAC Associates"),
respectively. SAC Associates is not listed as a Reporting Person on this
Schedule 13D because all voting and investment power (as defined in Rule 13d-3)
has been vested with SAC Advisors pursuant to an Investment Management
Agreement.
This Amendment No. 3 is filed to report that, pursuant to their terms, the
Warrants and the Convertible Notes issued to the Reporting Persons on November
8, 1996 pursuant to a Convertible Loan and Warrant Agreement (the "Agreement")
with the Company, as described in Amendment No. 2 to Schedule 13D, filed on
November 12, 1996, will become exercisable and convertible for shares of Common
Stock on July 1, 1997. Therefore, pursuant to Rule 13d-3(d), as of May 2,
1997, the Reporting Persons were deemed to be the beneficial owners of the
shares of Common Stock of the Company that the Reporting Persons may purchase
upon the exercise and conversion of the Warrants and Convertible Notes. This
Amendment updates the Reporting Person's previous disclosures.
ITEM 1. SECURITY AND ISSUER
No amendment.
ITEM 2. IDENTITY AND BACKGROUND
No amendment.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
No amendment.
ITEM 4. PURPOSE OF TRANSACTION
No amendment.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) The Reporting Persons beneficially own 7,246,200 Shares representing
17.66% of the 41,030,591 Shares outstanding (which number represents
the 36,030,591 Shares outstanding as of February 10, 1997 as reported
in the Company's Form 10-Q dated February 14, 1997, plus 2,500,000
additional Shares which would be issued by the Company upon conversion
of the Notes and the 2,500,000 additional Shares which would be issued
by the Company upon exercise of the Warrants). The number of Shares
beneficially owned includes the rights to acquire Common Stock
pursuant to certain Warrants and Convertible Notes which become
exercisable and convertible on July 1, 1997 pursuant to the terms of
the Agreement and the Warrants. The number of shares indicated above
as being beneficially owned and outstanding assumes that the
<PAGE> 5
SCHEDULE 13D
- ---------------------------------- ------------------------------------
CUSIP No. 91154J101 Page 5 of 5 Pages
--------------------- ---------- --------
- ---------------------------------- ------------------------------------
price of the Common Stock is $2.00 per share for purposes of the
conversion of the Convertible Note. As reported in Amendment No. 2,
this price is subject to certain adjustments upon the occurrence of
certain events and therefore the number of shares beneficially owned
by the Reporting Persons and the number of outstanding shares on July
1, 1997 may be different from the numbers indicated in this Amendment
No. 3 to the Schedule 13D.
(b) The Reporting Persons have not engaged in any transactions regarding
the Common Stock in the last sixty days.
(c) No amendment.
(d) No amendment.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
No amendment.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
None
After reasonable inquiry and to the best knowledge and belief of each, the
undersigned hereby certify that the information set forth in this statement is
true, complete, and correct.
Dated this 13th day of May, 1997.
S.A.C. CAPITAL ADVISORS, LLC
By: /s/ Scott J. Lederman, Esq. /s/ Steven A. Cohen
-------------------------------- --------------------------------
Scott J. Lederman, Esq. Steven A. Cohen
